Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.14
-0.3100-6.97%
Post-market: 4.00-0.1397-3.37%19:50 EDT
Volume:487.50K
Turnover:2.03M
Market Cap:307.20M
PE:-1.81
High:4.36
Open:4.36
Low:4.09
Close:4.45
Loading ...

U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart

Reuters
·
17 Dec 2024

Bain Capital Life Sciences Opportunities Iv, L.p. Reports 9.99% Passive Stake in Olema Pharmaceuticals Inc as of Dec 4 - SEC Filing

THOMSON REUTERS
·
12 Dec 2024

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
11 Dec 2024

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Dec 2024

Olema Pharmaceuticals: Promising Clinical Data and Growth Potential Warrant a Buy Rating

TIPRANKS
·
11 Dec 2024

Olema Pharmaceuticals Advances Breast Cancer Treatments

TIPRANKS
·
10 Dec 2024

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination With Ribociclib at the San Antonio Breast Cancer Symposium

THOMSON REUTERS
·
10 Dec 2024

Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium

GlobeNewswire
·
10 Dec 2024

Novartis Announces Positive Results From Late-Stage Study on Fabhalta

Zacks
·
10 Dec 2024

Olema Pharmaceuticals Cleared to Begin Testing Prospective Breast Cancer Candidate

MT Newswires Live
·
09 Dec 2024

Olema Pharmaceuticals Shares Rise 8.9% on FDA Approval of Cancer Drug Application

Dow Jones
·
09 Dec 2024

BRIEF-Olema Oncology Announces FDA Clearance Of Investigational New Drug Application For OP-3136

Reuters
·
09 Dec 2024

Olema Pharmaceuticals Inc - Phase 1 Clinical Trial for Op-3136 to Start Early 2025

THOMSON REUTERS
·
09 Dec 2024

Olema Oncology Announces FDA Clearance of Investigational New Drug Application for Op-3136, a Potent Kat6 Inhibitor

THOMSON REUTERS
·
09 Dec 2024

Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion

Zacks
·
04 Dec 2024

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
02 Dec 2024